Search

Your search keyword '"Gevaert, Philippe"' showing total 53 results

Search Constraints

Start Over You searched for: Author "Gevaert, Philippe" Remove constraint Author: "Gevaert, Philippe" Publisher elsevier bv Remove constraint Publisher: elsevier bv
53 results on '"Gevaert, Philippe"'

Search Results

1. Rhinitis control and medication use in a real-world sample of patients with persistent rhinitis or rhinosinusitis: a community pharmacy study

2. Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial

3. The unified airway hypothesis: evidence from specific intervention with anti-interleukin-5 biologic therapy

5. Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology

7. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial

8. Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps

9. Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies

10. Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

12. Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a phase 1 study

14. Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps

15. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

16. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

17. Mepolizumab Improves Health Related Quality of Life for Patients with Chronic Rhinosinusitis with Nasal Polyps: Data from the SYNAPSE study

18. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management

19. Reply

21. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials

22. Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop

23. Omalizumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps Irrespective of Asthma Status

24. Omalizumab Improves Quality of Life in Patients with Chronic Rhinosinusitis with Nasal Polyps and Comorbid Asthma

25. Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32

26. Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32

27. Atopic Comorbidities and Biomarkers of Type 2 Inflammation in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) Who Failed Intranasal Corticosteroids

30. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial

31. Reliable mite-specific IgE testing in nasal secretions by means of allergen microarray

32. Dupilumab Improves Sense of Smell and Reduces Anosmia Among Patients with Nasal Polyposis and Chronic Sinusitis: Results from a Phase 2a Trial

33. The quest for autoreactive antibodies in nasal polyps

38. Reply

43. Oral steroids and doxycycline: Two different approaches to treat nasal polyps

45. T-cell regulation in chronic paranasal sinus disease

Catalog

Books, media, physical & digital resources